Financial Report
1 January - 31 December
|
kEUR |
2023 |
2022 |
|
|
|
|
|
|
|
Revenue |
320,372 |
280,978 |
|
|
Other operating income |
4,481 |
2,486 |
|
|
Total income |
|
324,853 |
283,464 |
|
|
|
|
|
|
Cost of sales |
|
-315,730 |
-228,987 |
|
Gross profit / (loss) |
|
9,123 |
54,477 |
|
|
|
|
|
|
Marketing and sales expenses |
-4,053 |
-4,905 |
|
|
Research expenses |
-1,465 |
-1,243 |
|
|
General and administrative expenses |
-40,073 |
-35,722 |
|
|
Total operating expenses |
|
-45,591 |
-41,870 |
|
|
|
|
|
|
Operating result (EBIT) |
|
-36,468 |
12,607 |
|
|
|
|
|
|
Financial income |
103 |
9 |
|
|
Financial expenses |
-21,878 |
-5,049 |
|
|
Total financial result |
|
-21,775 |
-5,040 |
|
|
|
|
|
|
Result before income taxes |
|
-58,243 |
7,567 |
|
|
|
|
|
|
Income tax |
6,803 |
200 |
|
|
Result for the year |
|
-51,440 |
7,767 |
|
|
|
|
|
|
Attributable to shareholders of PolyPeptide Group AG |
|
-51,440 |
7,767 |
|
|
|
|
|
|
Earnings per share in EUR, basic |
-1.56 |
0.24 |
|
|
Earnings per share in EUR, diluted |
-1.56 |
0.24 |